fda import alert semaglutide tirzepatide green list Demurs on GLP-1 Compounding Fight, Debuts Consumer 'Green List' Instead FDA Launches 'Green List' to

Mounjaro is a first-in-class drug that activates both GIP and GLP-1 receptors, improving blood sugar control through a dual mechanism of action

A pilot study of men with metabolic hypogonadism found that tirzepatide increased testosterone by 128.5% over two months, outperforming testosterone replacement therapy, which produced only a 46.2% increase

Regular check-ins, dose adjustments, and ongoing monitoring ensure you're getting results, not just taking medication and hoping

Focus on tolerance

An adjusted indirect treatment comparison (aITC) was conducted using data from the SURPASS-2 and SUSTAIN FORTE trials

The solution usually involves adjusting caloric intake, increasing activity, or discussing a dose escalation with their prescriber, not changing injection timing